Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.68 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.63 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.63 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.63 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 5/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | MEN1 | O00255 | 3/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | SCN4A | P35499 | 2/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | NPY1R | P25929 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11303021 | 0.87 | LMNA (0.65) | KDM4ECYP1A2ADRB2ADRB1ADRB3 | |
| SCHEMBL18423672 | 0.86 | KDM4E (0.82) | KDM4ECYP1A2ADRB2ADRB1ADRB3 | |
| SCHEMBL7120229 | 0.86 | KDM4E (0.70) | KDM4ECYP1A2ADRB2ADRB1ADRB3 | |
| SCHEMBL9120285 | 0.85 | KMT2A (0.50) | KDM4ECYP1A2ADRB2ADRB1ADRB3 | |
| SCHEMBL14290588 | 0.85 | KMT2A (0.50) | KDM4ECYP1A2ADRB2ADRB1ADRB3 | |
| SCHEMBL8047112 | 0.83 | KDM4E (0.61) | KDM4ECYP1A2ADRB2ADRB1ADRB3 | |
| SCHEMBL17813019 | 0.83 | KDM4E (0.61) | KDM4ECYP1A2ADRB2ADRB1ADRB3 | |
| SCHEMBL11104803 | 0.82 | KDM4E (0.66) | KDM4ECYP1A2ADRB2ADRB1ADRB3 | |
| SCHEMBL10635992 | 0.82 | ALOX15 (0.47) | KDM4ECYP1A2ADRB2ADRB1ADRB3 | |
| Mephenesin SCHEMBL6482337 | 0.81 | CYP1A2 (1.00) | KDM4ECYP1A2ADRB2ADRB1ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11083192-B2 | Fertilizer and agrochemical formulation | MITSUI CHEMICALS AGRO, INC. (JP) | 2021-08-10 | — | — | US | claimed |
| US-20190320651-A1 | FERTILIZER AND AGROCHEMICAL FORMULATION | MITSUI CHEMICALS AGRO, INC. (JP) | 2019-10-24 | — | — | US | claimed |
| US-10375951-B2 | Fertilizer and agrochemical formulation | MITSUI CHEMICALS AGRO, INC. (JP) | 2019-08-13 | — | — | US | claimed |
| US-20180139954-A1 | FERTILIZER AND AGROCHEMICAL FORMULATION | MITSUI CHEMICALS AGRO, INC. (JP) | 2018-05-24 | — | — | US | claimed |
| WO-2016170784-A1 | FERTILIZER AND AGROCHEMICAL FORMULATION | MITSUI CHEMICALS AGRO, INC. (JP) | 2016-10-27 | — | — | WO | claimed |
| US-6248314-B1 | Hair dye composition having a particular buffer capacity and containing an alkylene carbonate | KAO CORPORATION (JP) | 2001-06-19 | — | — | US | claimed |
| EP-1022014-A1 | Hair dye composition | Kao Corporation (JP) | 2000-07-26 | — | — | EP | claimed |
| US-11541041-B1 | Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, Rasopathies, and fibrotic disease | SHY Therapeutics LLC (US) | 2023-01-03 | — | — | US | disclosed |
| US-11538992-B2 | Formulation of an organic functional material | MERCK PATENT GMBH (DE) | 2022-12-27 | — | — | US | disclosed |
| WO-2022019035-A1 | INK SET AND MAINTENANCE METHOD | 富士フイルム株式会社 | 2022-01-27 | — | — | WO | disclosed |
| US-11083192-B2 | Fertilizer and agrochemical formulation | MITSUI CHEMICALS AGRO, INC. (JP) | 2021-08-10 | — | — | US | disclosed |
| EP-3532565-B1 | FORMULATION OF AN ORGANIC FUNCTIONAL MATERIAL | MERCK PATENT GMBH (DE) | 2021-04-21 | — | — | EP | disclosed |
| EP-3532565-B1 | FORMULATION OF AN ORGANIC FUNCTIONAL MATERIAL | MERCK PATENT GMBH (DE) | 2021-04-21 | — | — | EP | disclosed |
| US-6248314-B1 | Hair dye composition having a particular buffer capacity and containing an alkylene carbonate | KAO CORPORATION (JP) | 2001-06-19 | — | — | US | disclosed |
| CN-1284941-A | Novel antiarrhythmic compounds | PHARMACEUTICAL RES INST PUBLIC (HU) | 2001-02-21 | — | — | CN | disclosed |
| WO-2000076984-A2 | NOVEL COMPOUNDS, THEIR USE AND PREPARATION | BIOVITRUM AB (SE) | 2000-12-21 | — | — | WO | disclosed |
| EP-1022014-A1 | Hair dye composition | Kao Corporation (JP) | 2000-07-26 | — | — | EP | disclosed |
| EP-0492615-B1 | Process for producing biguanide derivative | IDEMITSU KOSAN CO (JP) | 1995-03-08 | — | — | EP | disclosed |
| US-5286905-A | Heating hydrogen halide salt of phenoxyalkylamine with dicyandiamide in paraffinic hydrocarbon solvent | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1994-02-15 | — | — | US | disclosed |
| EP-0492615-A1 | Process for producing biguanide derivative | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1992-07-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11541041-B1 | Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, Rasopathies, and fibrotic disease | HRAS, KRAS, NRAS | KDM4E 4215/4885CYP1A2 4764/4885ADRB2 3974/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.